Metabolic Research

This shelf groups incretin and related metabolic-pathway research solids for Canadian laboratories. It is a topical catalog hub: receptor class, lot documentation, and links into the research notes. It is not a clinical overview and it is not a single product page.

Research use only. Not for human or veterinary use.

Materials in this group

Incretin and metabolic-pathway research

Editorial laboratory context. Price, stock, and SKU come from the catalog cards above, not from this note.

Incretin and metabolic-pathway research peptides are defined amino-acid chains used to study receptor signalling in laboratory models. This shelf groups four incretin and amylin ligand families, plus one prohibitin-targeting peptidomimetic, that purchasing offices often source together. Published papers and trial registries name the receptors. Those names are literature labels. They are not measurements of a BlueNex Labs vial, and they are not instructions for a person or an animal.

The four live families stay distinct. Public trial literature describes retatrutide as a ligand at GLP-1, GIP, and glucagon receptors. Tirzepatide is described as a dual GLP-1 and GIP receptor ligand. Semaglutide is described as a GLP-1 receptor ligand. Cagrilintide is described as an amylin-analogue research solid. A shared category URL does not make the sequences interchangeable, and it does not create a Health Canada authorization.

Retatrutide strengths are separate listings. Retatrutide 10 mg, Retatrutide 20 mg, and Retatrutide 30 mg each keep their own price and stock. Tirzepatide 10 mg and Tirzepatide 30 mg are separate listings. Semaglutide lists 10 mg and 20 mg on one shop URL. Cagrilintide 5 mg is a single fill. Adipotide 10 mg, also cited as FTPP, is the prohibitin-targeting peptidomimetic on this shelf. Preclinical papers, including a 2011 nonhuman-primate study, describe prohibitin on adipose vasculature. It is not an incretin receptor ligand and it is not the amylin analogue. Milligram size, CAD price, and stock stay on the product page. This note does not set them. A 10 mg certificate does not document a 30 mg vial from another lot. No certificates-library row is published for adipotide.

Methods papers in this area report receptor binding and second-messenger readouts in the cell systems the authors ran. The GLP-1 peptide research in 2026 note keeps that frame. The retatrutide trial literature note and the FDA status and TRIUMPH note separate sponsor programs from a research-use-only catalogue lot. The FAQ on catalogue vials and trial drug products states the same limit.

Start with the receptor class, open one product URL, then open the lot file when the library has one. Sold-out sizes stay visible and cannot be added to the cart. A sold-out card is not a backorder. Matrix peptides, secretagogues, and bacteriostatic water are other category hubs. Filing those classes under one certificate is a documentation error.

Research use only. Not for human or veterinary use.

Documentation and lot files

A Certificate of Analysis on this shelf is a file for one lot. An HPLC or UPLC area percent and a mass result answer different questions. Endotoxin is present only when that row links an endotoxin file. Read what a peptide COA records before a lot is filed. Match cap colour, milligram size, and the sample name to the PDF in hand.

Retatrutide rows are filed by cap and by shop URL. A 10 mg report does not document a 20 mg or 30 mg cake. The blue-cap row is the retatrutide 10 mg row. The purple-cap row is the retatrutide 20 mg row. The pink-cap row is the retatrutide 30 mg row. Tirzepatide 10 mg is the tirzepatide 10 mg row. Tirzepatide 30 mg is the tirzepatide 30 mg row. Semaglutide and cagrilintide keep their own anchors when a report is published. Adipotide 10 mg has no certificates-library anchor yet. An incretin or amylin report does not document that vial. This note is not a substitute for that PDF.

Canada fulfilment

BlueNex Labs ships inside Canada only, on Canada Post Xpresspost, after Interac e-Transfer. The desk is 4309 Canada Way, Burnaby, BC V5G 1J3. Xpresspost labels use a Port Moody PO Box as the sender. That box is the carrier account. It is not a second warehouse. Shipping is $25.00 flat rate; free on product subtotals of $299.00 or more. The FAQ on U.S. reshippers states the same Canada-only limit.

Materials in this group are sold for laboratory and in-vitro work. They are not medicines, foods, cosmetics, or veterinary products, and BlueNex Labs does not provide administration guidance. Research-use-only labelling is not a Health Canada authorization.

Questions about this catalogue group

What does research use only mean for incretin-class vials?

Research use only means the lyophilized solid is sold for laboratory and in-vitro work, not as a medicine, food, cosmetic, or veterinary product. The label is not a Health Canada drug authorization and it does not include instructions for personal use.

Does one Certificate of Analysis cover every incretin fill?

No. Library entries are lot-specific. A report for one milligram size does not document a different size or a different compound. Match the vial in hand to the certificates library anchor before the material enters a study file.

How does BlueNex Labs ship metabolic research peptides in Canada?

Checkout uses a Canadian address and Interac e-Transfer. Parcels move on Canada Post Xpresspost. The desk is in Burnaby, and the sender line uses a Port Moody PO Box. The catalogue does not ship outside Canada.

Research peptide FAQ

Research categories